Back to Journals » Cancer Management and Research » Volume 13

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

Total article views   HTML views PDF downloads Totals
4,798 Dovepress* 4,519+ 422 4,941
PubMed Central* 279 112 391
Totals 4,798 534 5,332
*Since 15 February 2021

View citations on PubMed Central and Google Scholar